Safety and Efficacy of Iptacopan in Patients With High-Risk Transplantation-Associated Thrombotic Microangiopathy
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Clinical Trials Related to Iptacopan
Related studies linked through entity extraction aliases.
Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Iptacopan in Pediatric Patients With Primary IgAN
- Status
- RECRUITING
- Phase
- PHASE3
Post-authorization Safety Study of Iptacopan in Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Using Data From the IPIG PNH Registry
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
A Multicenter Prospective Study of Iptacopan in the Treatment of Refractory/Relapsed Autoimmune Hemolytic Anemia (AIHA)
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Study to Evaluate the Impact of Iptacopan on Top of SOC on Biopsy Changes in Kidneys of Adult Patients With IgAN
- Status
- RECRUITING
- Phase
- PHASE2
A Phase III Study to Investigate Efficacy, Safety and Tolerability of Iptacopan Compared With Placebo in Participants Aged 18 to 85 Years With gMG.
- Status
- RECRUITING
- Phase
- PHASE3
Iptacopan in Patients With ANCA Associated Vasculitis
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Efficacy and Safety of Switching From Anti-C5 Antibody Treatment to Iptacopan Treatment in Study Participants With Atypical Hemolytic Uremic Syndrome (aHUS)
- Status
- RECRUITING
- Phase
- PHASE3
Study of Efficacy and Safety of Iptacopan in Participants With IC-MPGN
- Status
- RECRUITING
- Phase
- PHASE3
Single Arm, Open Label Trial With Iptacopan Treatment for 24 Weeks, in Patients on Stable Regimen of Anti-C5 Who Switch to Iptacopan.
- Status
- COMPLETED
- Phase
- PHASE3
Managed Access Programs for LNP023, Iptacopan
- Status
- AVAILABLE
- Phase
- N/A
Basket Study to Assess Efficacy, Safety and PK of Iptacopan (LNP023) in Autoimmune Benign Hematological Disorders
- Status
- TERMINATED
- Phase
- PHASE2
Pharmacokinetic (PK) and Safety Study of Iptacopan (LNP023) in Participants With Mild, Moderate, and Severe Hepatic Impairment Compared to Matched Control Healthy Participants With Normal Hepatic Function.
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety of Iptacopan (LNP023) in Adult Patients With Atypical Hemolytic Uremic Syndrome Naive to Complement Inhibitor Therapy
- Status
- COMPLETED
- Phase
- PHASE3
Study of Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy.
- Status
- RECRUITING
- Phase
- PHASE3
Long-term Safety and Tolerability of Iptacopan in Patients With Paroxysmal Nocturnal Hemoglobinuria
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Study of Safety, Efficacy, Tolerability, Pharmacokinetics and Pharmacodynamics of LNP023 in in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)
- Status
- COMPLETED
- Phase
- PHASE2